Dec 7, 2011 8:00 am EST Acasti Pharma to Present at The American Academy of Anti-Aging Medicine (A4M) and to The American Academy of Private Physicians
Dec 5, 2011 8:00 am EST Acasti Pharma Announces the Initiation of a Second Phase II Clinical Study and Consolidation of Its IP Position
Oct 17, 2011 8:00 am EDT Acasti Pharma Inc. Receives Health Canada Clearance for an Open-Label Phase II Hypertriglyceridemia Trial
Oct 4, 2011 9:08 am EDT Acasti Pharma Announces the Initiation of Phase II Clinical Study of CaPre(R) for the Treatment of Hypertriglyceridemia